Brant Point Investment Management »

Ligand Pharmaceuticals In shares owned by Brant Point Investment Management

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Brant Point Investment Management from 13F filings

Historical chart of Brant Point Investment Management investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Brant Point Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Brant Point Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 200 10009.00
2015-09-30 $857k 10k 85.70
2015-06-30 $5.0M 50k 100.90

More positions owned by Brant Point Investment Management

Fiserv Put Option (FI)
AECOM Technology Corporation Put Option (ACM)
Cooper Cos Com New Put Option
Unum Call Option (UNM)
Icon SHS Put Option (ICLR)
Brink's Company Put Option (BCO)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Put Option (MDY)
O'reilly Automotive (ORLY)
Amphenol Corp Cl A (APH)
Arthur J. Gallagher & Co. (AJG)
Performance Food (PFGC)
Amazon (AMZN)
Us Foods Hldg Corp call (USFD)

View all positions for Brant Point Investment Management

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Macquarie Group
State Street Corporation
Dimensional Fund Advisors
Congress Asset Management
Stephens Investment Management Group
Chicago Capital
Geode Capital Management
Loomis, Sayles and
Ashford Capital Management
Rice Hall James & Associates
Deutsche Bank Aktiengesellschaft
St. Denis J. Villere & Co

View all funds holding Ligand Pharmaceuticals In